Back to top

Verastem (VSTM) in Focus: Stock Moves 8% Higher

Read MoreHide Full Article

Verastem, Inc. (VSTM - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.88 to $3.43 in the past one-month time frame.

Although the company has seen no estimate revisions in the past one month, its Zacks Consensus Estimate has also moved lower over the past two months, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Verastem currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Verastem, Inc. Price and Consensus

Investors interested in the Medical - Biomedical and Genetics industry may consider a better ranked stock Ligand Pharmaceuticals Incorporated (LGND - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is VSTM going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Ligand Pharmaceuticals Incorporated (LGND) - free report >>

Verastem, Inc. (VSTM) - free report >>


More from Zacks Tale of the Tape

You May Like